Intractable Pain Clinical Trial
Official title:
Acceptance-Based Treatment for Chronic Pain
The purpose of the study is to test a brief, group-administered psychosocial intervention to reduce interference of pain with daily life, emotional distress, and pain intensity, and improve quality of life and physical activity levels in individuals with chronic pain.
Chronic pain affects at least 15% of the veteran population and represents a high priority
for the VA. In addition to primary pain conditions, chronic pain is a common secondary
condition resulting from battlefield injuries, traumatic accidents, and congenital and
acquired disorders. Unlike most forms of acute pain, treatment options available for
patients suffering from chronic pain frequently offer only short-term or partial relief from
symptoms. The focus of rehabilitative intervention thus becomes the reduction of disability
and emotional distress and improvement in quality of life and activity levels.
Chronic pain rehabilitation has evolved from a primarily one-dimensional, medically oriented
approach to a multidisciplinary approach that incorporates a biopsychosocial formulation to
pain management with physiological, cognitive, behavioral, and emotional components. This
conceptualization of pain recognizes that multiple intervention modalities, including
psychosocial approaches, are required when providing treatment to chronic pain patients.
A relatively new psychosocial approach to chronic pain management and rehabilitation
involves acceptance of pain-related experiences. The Acceptance-based Therapy (AT) model is
based on the theory that attempts to escape, avoid, or control negative experiences that
cannot be changed, such as chronic pain, may paradoxically contribute to the increased
experience of them. Instead of seeking to control the negative experience, AT teaches
individuals to use mindfulness strategies to enlarge the scope of experience beyond pain and
to engage in behaviors that are consistent with personal values and goals when total
elimination of pain or other negative experiences is not possible. Empirical support for
acceptance-based approaches to chronic pain management is growing. Data from one of the
first comparisons of AT to a well-established psychosocial intervention,
Cognitive-Behavioral Therapy (CBT), performed at VASDHS by the PI, suggests that AT may be
superior to CBT as an adjunctive treatment for chronic pain.
The proposed study assembles a multidisciplinary team with extensive experience in chronic
pain interventions research to evaluate the benefits of a brief, manualized
group-administered psychosocial intervention which could be easily integrated into
multidisciplinary pain rehabilitation programs throughout the VA system to reduce disability
in veterans with chronic pain secondary to other conditions. Specifically, we propose to
examine the effects of a promising new chronic pain intervention based on AT principles on
the primary outcome of pain interference and secondary outcomes of emotional distress,
quality of life, physical activity, pain intensity, and treatment satisfaction among 94
veterans with chronic benign pain as a secondary condition. The AT intervention will be
compared with treatment as usual (TAU) in a within-subjects design and with CBT in a
randomized, between-subjects design. Outcomes include an objective measure of physical
activity, actigraphy, as well as self-reported measures and will be evaluated at baseline, 6
weeks (after a TAU phase), 12 weeks (after treatment), and at a 6-month follow-up period to
investigate maintenance of gains. The study design also allows for an investigation of
hypothesized mechanisms of change, acceptance (for AT) and perceived pain control (for CBT).
Thus, the proposed project has the potential to enhance the current VA standard of care as
well as to add to the scientific literature on psychological models and rehabilitation of
chronic pain.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00996983 -
Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer
|
Phase 2 | |
Withdrawn |
NCT03876158 -
Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)
|
Phase 4 | |
Not yet recruiting |
NCT02522611 -
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
|
Phase 1/Phase 2 | |
Recruiting |
NCT04909593 -
Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial
|
N/A | |
Terminated |
NCT02587130 -
Ketamine and Refractory Painful Care in a Palliative Unit
|
Phase 4 | |
Terminated |
NCT03886753 -
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
|
||
Completed |
NCT03082261 -
Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator
|
N/A | |
Completed |
NCT01854229 -
Prometra Post-Approval Study
|
N/A | |
Completed |
NCT01291901 -
NP2 Enkephalin For Treatment of Intractable Cancer Pain
|
Phase 2 | |
Completed |
NCT00817596 -
Prometra's Utilization in Mitigating Pain (PUMP)
|
N/A | |
Completed |
NCT01567345 -
Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow
|
N/A | |
Terminated |
NCT00387244 -
Efficacy of the Spinal Cord Stimulation System as Salvage Therapy
|
N/A | |
Recruiting |
NCT00804154 -
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
|
Phase 1 | |
Approved for marketing |
NCT00866164 -
Prometra's Utilization in Mitigating Pain II
|
N/A |